ArticleEuropean heart journal. Cardiovascular pharmacotherapy2017

Response to comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.

Faiez ZannadPubMed ↗Publisher ↗

No numbers read from the abstract.